no code implementations • 16 Oct 2023 • Thanh Tung Khuat, Robert Bassett, Ellen Otte, Alistair Grevis-James, Bogdan Gabrys
While machine learning (ML) has made significant contributions to the biopharmaceutical field, its applications are still in the early stages in terms of providing direct support for quality-by-design based development and manufacturing of biopharmaceuticals, hindering the enormous potential for bioprocesses automation from their development to manufacturing.
